Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

PYRETHRINS & PIPERONYL BUTOXIDE

All products: general benefit

Other products in the same Health Canada class (P03A, P03AC) — coverage varies; not interchangeable

  • Permethrin (Nix Dermal Cream): general benefit
  • Dimethicone (Nyda): general benefit
  • Isopropyl myristate (Resultz): general benefit

R & C Shampoo with Conditioner · DIN 02125447 · 0.33% & 3% · Topical Shampoo

General benefitDormant since 2026-08-11 · checked 2026-09-02 · What does dormant mean?
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
No interchangeable product listed in the Ontario extract
R & C Shampoo with Conditioner · DIN 02125447 Manufacturer: MedTech Products Inc.; listing date 1997-04-10 Health Canada: Dormant since 2026-08-11 · brand R & C SHAMPOO WITH CONDITIONER · ATC P03AC51 PYRETHRUM, COMBINATIONS · form Shampoo · route Topical · ingredients PYRETHRINS 0.33 %, PIPERONYL BUTOXIDE 3 % · company Medtech products inc · schedule Non-prescription drugs
Check this DIN again · Health Canada product record

R & C Shampoo with Conditioner: Formulary list price $0.1110/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.1110 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18634 · Verify on the e-Formulary ↗ (DIN 02125447)

Source record
DIN 02125447: R & C Shampoo with Conditioner Raw flags: sec3=Y Item: 840412009; group id 829; item number 2018; lccId None; manufacturer id MEP Source form: Topical Shampoo; strength: 0.33% & 3% Recorded listing: General benefit Source prices (unrounded): $0.1110; ministry $0.1110 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=02125447 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=18634
Shortage status: no shortage or discontinuation reported (checked 2026-09-13T08:10:21.292534+00:00); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=02125447
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Health Canada lists this DIN as Dormant since 2026-08-11 — choose a marketed DIN from the same-category list.
Other drugs in the same formulary class (84:04:12 Parasiticides) and how they are covered

Matched class: 84:04:12 Parasiticides

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Covered without a code on the Ontario formulary: DIMETHICONE., ISOPROPYL MYRISTATE, PERMETHRIN 84:04:12 Parasiticides

PERMETHRIN

· 4 products · General benefit · strengths: 5%, 1% · Cr, Cr Rinse, Lot

DIMETHICONE.

· 1 products · General benefit · strengths: 50% w/w · Top Sol-50mL Pk

ISOPROPYL MYRISTATE

· 2 products · General benefit · strengths: 50% · Top Sol-120mL Pk, Top Sol-240mL Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 84:04:12
Full class listing Related classes: 84:04:04 Antibiotics, 84:04:08 Fungicides, 84:04:16 Other Anti-Infectives Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
Product monograph unavailable: no marketed product found
Health Canada: dormant products
Health Canada defines dormant products as: “products that were previously marketed in Canada but for which the manufacturer has suspended sale for period of at least 12 months.” (canada.ca, Sep 10, 2026 ↗)